Esperanza Cañas-Ruano

6PUBLICATIONS
33CO-AUTHORS
Medical virologyPharmacogenomicsPharmaceutical delivery technologiesInfectious diseasesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 10, 2026
Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.

María De Lagarde, Rosa De Miguel, Mayra A Sigcha

|Mar 07, 2025
Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial.

Rosa De Miguel, María de Lagarde Sebastian, José Luis Blanco Arévalo

|Jul 26, 2023
Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study.

Hernando Knobel, Esperanza Cañas-Ruano, Ana Guelar

|Nov 11, 2022
Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.

Elena Sendra, Inmaculada López Montesinos, Alicia Rodriguez-Alarcón

|May 28, 2022
An Abnormal Inflammatory Pattern Associated with Long-Term Non-Progression of HIV Infection Impacts Negatively on Bone Quality.

Jade Soldado-Folgado, Juan José Chillarón, Esperanza Cañas-Ruano

|May 17, 2021
Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48-week follow-up study.

A Albasanz-Puig, P Suanzes, J Esperalba

Pageof 1

Frequent Collaborators

2 joint publications

Luz Martin-Carbonero

2 joint publications

Jose R Arribas

2 joint publications

Arkaitz Imaz

2 joint publications

Angela Gutiérrez Liarte